![(PDF) Association among PlA1/A2 gene polymorphism, laboratory aspirin resistance and clinical outcomes in patients with coronary artery disease: An updated meta-analysis (PDF) Association among PlA1/A2 gene polymorphism, laboratory aspirin resistance and clinical outcomes in patients with coronary artery disease: An updated meta-analysis](https://i1.rgstatic.net/publication/335748943_Association_among_PlA1A2_gene_polymorphism_laboratory_aspirin_resistance_and_clinical_outcomes_in_patients_with_coronary_artery_disease_An_updated_meta-analysis/links/5fb6484c92851c933f3d7ba8/largepreview.png)
(PDF) Association among PlA1/A2 gene polymorphism, laboratory aspirin resistance and clinical outcomes in patients with coronary artery disease: An updated meta-analysis
![PDF) Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial PDF) Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial](https://i1.rgstatic.net/publication/335240369_Efficacy_of_TIMOLOL_nasal_spray_as_a_treatment_for_epistaxis_in_hereditary_hemorrhagic_telangiectasia_A_double-blind_randomized_placebo-controlled_trial/links/5d5a988d299bf1b97cf5496d/largepreview.png)
PDF) Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial
![On the Challenges of Cosmic-Ray Proton Shock Acceleration in the Intracluster Medium - ScienceDirect On the Challenges of Cosmic-Ray Proton Shock Acceleration in the Intracluster Medium - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1384107620304565-gr3.jpg)
On the Challenges of Cosmic-Ray Proton Shock Acceleration in the Intracluster Medium - ScienceDirect
![PDF) From transplant to novel cellular therapies in multiple myeloma: EMN guidelines and future perspectives PDF) From transplant to novel cellular therapies in multiple myeloma: EMN guidelines and future perspectives](https://i1.rgstatic.net/publication/321672076_From_transplant_to_novel_cellular_therapies_in_multiple_myeloma_EMN_guidelines_and_future_perspectives/links/5a84d5b04585159152b80d2c/largepreview.png)
PDF) From transplant to novel cellular therapies in multiple myeloma: EMN guidelines and future perspectives
![Frontiers | Salidroside Inhibits Myogenesis by Modulating p-Smad3-Induced Myf5 Transcription | Pharmacology Frontiers | Salidroside Inhibits Myogenesis by Modulating p-Smad3-Induced Myf5 Transcription | Pharmacology](https://www.frontiersin.org/files/Articles/337325/fphar-09-00209-HTML-r1/image_m/fphar-09-00209-g002.jpg)
Frontiers | Salidroside Inhibits Myogenesis by Modulating p-Smad3-Induced Myf5 Transcription | Pharmacology
![PDF) Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management. PDF) Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management.](https://i1.rgstatic.net/publication/332962610_Metastatic_bone_disease_Pathogenesis_and_therapeutic_options_Up-date_on_bone_metastasis_management/links/5ceced37458515026a614240/largepreview.png)
PDF) Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management.
![PDF) NEMA NU 2012 Performance Evaluation of Silicon-Photomultiplier– Based and conventional PMT-based Time-of-Flight systems PDF) NEMA NU 2012 Performance Evaluation of Silicon-Photomultiplier– Based and conventional PMT-based Time-of-Flight systems](https://i1.rgstatic.net/publication/344366720_NEMA_NU_2012_Performance_Evaluation_of_Silicon-Photomultiplier-_Based_and_conventional_PMT-based_Time-of-Flight_systems/links/5f6cd60e458515b7cf4c3e15/largepreview.png)